Interpret the provided CBC and iron studies and recommend appropriate management for the likely iron‑deficiency anemia.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Laboratory Interpretation and Management Recommendation

This patient has mild iron deficiency anemia (IDA) with clear laboratory evidence of iron depletion, and should be started on oral iron supplementation (30-100 mg elemental iron daily) while simultaneously investigating the underlying cause of iron loss.

Laboratory Analysis

Abnormal Findings Indicating Iron Deficiency Anemia:

  • Hemoglobin 12.1 g/dL (Low): Below the WHO threshold of 13.2 g/dL for women, confirming anemia 1
  • Hematocrit 38.7% (Low): Consistent with anemia
  • MCHC 31.3 g/dL (Low): Indicates hypochromia, a hallmark of iron deficiency
  • RDW 16.1% (High): Elevated red cell distribution width reflects anisocytosis typical of iron deficiency 2
  • Ferritin 265 mcg/L: While seemingly normal, this must be interpreted cautiously as ferritin is an acute phase reactant and can be falsely elevated with inflammation 1
  • Serum Iron 33 mcg/dL (Low): Significantly below normal range (50-180)
  • Transferrin Saturation 13%: Markedly reduced, strongly indicating iron deficiency 1

Key Diagnostic Points:

The combination of low transferrin saturation (13%), low serum iron, elevated RDW, and low MCHC definitively establishes iron deficiency despite the ferritin level of 265 mcg/L 1. The transferrin saturation below 20% is highly specific for iron deficiency 1. The MCV remains normal (87.4 fL), indicating this is relatively early or mild IDA before significant microcytosis develops—MCH and MCHC are more sensitive early markers 1.

Management Algorithm

1. Immediate Treatment - Oral Iron Supplementation

Start oral iron therapy with 30-100 mg of elemental iron daily as first-line treatment 3, 4. This is appropriate for mild anemia (Hb 12.1 g/dL) with good tolerance expected 4.

  • Oral iron is safe, effective, and cost-effective for most patients
  • Continue for at least 3-6 months to replete iron stores
  • Take on empty stomach if tolerated; with food if gastrointestinal side effects occur

2. Mandatory Investigation for Underlying Cause

All women with IDA require investigation regardless of menstrual history 1. Even with a ferritin of 265 mcg/L, the low transferrin saturation and low iron demand evaluation:

  • Detailed menstrual history: Heavy menstrual bleeding is the most common cause in reproductive-age women, but cannot be assumed 5
  • Gastrointestinal evaluation: Consider celiac disease screening (tissue transglutaminase antibodies), as 2-6% of asymptomatic IDA patients have celiac disease 3
  • Dietary assessment: Evaluate for inadequate iron intake, vegetarian/vegan diet
  • Medication review: NSAIDs, anticoagulants, aspirin causing occult GI blood loss
  • Consider endoscopy if no obvious gynecologic cause, especially if symptoms persist or patient fails to respond to oral iron 1

3. Follow-Up Monitoring

  • Recheck hemoglobin in 4-6 weeks to assess response to oral iron 4
  • Recheck ferritin and transferrin saturation in 8-12 weeks to confirm iron repletion
  • Expected hemoglobin rise: 1-2 g/dL over 3-4 weeks with adequate therapy

4. Escalation Criteria for IV Iron

Consider intravenous iron if 3, 4:

  • Intolerance to oral iron (significant GI side effects)
  • Failure to respond to oral iron after 4-6 weeks
  • Ongoing blood loss exceeding absorption capacity
  • Severe symptoms requiring rapid correction
  • Malabsorption (e.g., celiac disease with severe villous atrophy, inflammatory bowel disease)

Critical Pitfalls to Avoid

Do not dismiss iron deficiency based on "normal" ferritin alone. The ferritin of 265 mcg/L may reflect concurrent inflammation masking true iron depletion 1. The transferrin saturation of 13% is the definitive marker here—values below 20% indicate iron deficiency even when ferritin appears adequate 1.

Do not assume menstrual bleeding is the cause without investigation. While common in reproductive-age women, other causes (GI bleeding, celiac disease, malabsorption) must be excluded, particularly if response to iron is inadequate 3, 1.

Do not use blood transfusion. With hemoglobin of 12.1 g/dL, transfusion is not indicated and should be reserved only for life-threatening situations 4.

References

4
Research

Iron deficiency and new insights into therapy.

The Medical journal of Australia, 2017

5
Research

No. 469 Iron Deficiency and Iron Deficiency Anemia in Obstetrics and Gynaecology.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2026

Related Questions

What are alternative treatments for iron deficiency anemia patients who cannot tolerate ferrous sulfate?
Should women with iron‑deficiency anemia be treated with both ethinylestradiol (combined oral contraceptive) and ferrous gluconate iron supplementation, and when is this appropriate?
What is the most appropriate initial diagnostic test for an 18‑month‑old boy who is underweight, has pale conjunctiva, consumes excessive milk, and exhibits pica (eating dirt)?
In a 41-year-old woman with irregular menses, a copper intrauterine device, low ferritin indicating iron deficiency, and a markedly suppressed TSH with normal free T4, how should I manage iron replacement and what follow-up is recommended for the thyroid labs?
What is the appropriate management of iron deficiency identified on a complete blood count (CBC)?
How should the peripheral blood smear be interpreted in a patient with hairy cell leukemia who is negative for all common BRAF V600 (V600E, V600D, V600K, V600G, V600R) mutations?
What topical antibiotic ointment is appropriate to prescribe for a superficial skin lesion in a patient without mupirocin allergy and who is not pregnant?
In a 20‑year‑old woman with major depressive disorder, anxiety, post‑traumatic stress disorder, and obsessive‑compulsive disorder who has been hospitalized 4–5 times for suicide attempts in one year, what factors are driving her repeated attempts—is it primarily her OCD or other underlying issues?
How should centrally mediated abdominal pain be managed?
What is the recommended treatment for overactive bladder in paraplegic men?
What pharmacologic treatments are appropriate for constipation in an adult glioma patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.